A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastric and Colorectal Cancer Patients With FGFR Alterations Who Have Failed Standard Therapy
Clinical trial NCT05202236 · UNKNOWN
Trial details
- NCT number
- NCT05202236
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2023-10-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.